Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis

Kidney International

Volumn 58, Issue 3, 2000, Pages 1278-1284

  Baggio, Bruno ^a,b,c   Budakovic, Alessandro ^a,b,c   Angela Nassuato, Maria ^a,b,c   Vezzoli, Giuseppe ^a,b,c   Manzato, Enzo ^a,b,c   Luisetto, Giovanni ^a,b,c   Zaninotto, Martina ^a,b,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Calciotropic hormones; Hypercalciuria; Kidney stones; Lithogenesis; Renal stone formers

Indexed keywords

ALKALINE PHOSPHATASE; ARACHIDONIC ACID; CALCITRIOL; CALCIUM; FISH OIL; HYDROXYPROLINE; PARATHYROID HORMONE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E2;

ADULT; ARACHIDONIC ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCALCIURIA; IDIOPATHIC DISEASE; KIDNEY DISEASE; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; STONE FORMATION;

EID: 0033863337     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00283.x     Document Type: Article

References (49)

1. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis
2. The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis
3. 2 in urinary stone formation
4. 2 in patients with idiopathic hypercalciuria is a primary phenomenon
5. 2 in nephrolithiasic patients is mediated by inhibition of Na-K-2Cl cotransport activity, in Renal Stones: Aspects of Their Formation, Removal and Prevention, edited by Tiselius HG, Akademitryck AB, Sweden, Edsbruk
6. Dietary manipulation of delta-6-desaturase modifies phospholipid arachidonic acid levels, and the urinary excretion of calcium and oxalate in the rat: Insight in calcium lithogenesis
7. Abnormal erythrocyte and renal frusemide-sensitive sodium transport in idiopathic calcium nephrolithiasis
8. Calcium-regulating hormones and the kidney
9. Pathogenesis of idiopathic calcium nephrolithiasis: Update 1997
10. Abnormal arachidonic acid content of membrane phospholipids - The unifying hypothesis for the genesis of hypercalciuria and hyperoxaluria in idiopathic calcium nephrolithiasis
11. A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias
12. An inheritable anomaly of red-cell oxalate transport in 'primary' calcium nephrolithiasis correctable with diuretics
13. Immunoassay for quantifying type I collagen degradation products in urine evaluated
14. Strontium absorption and excretion in normocalciuric subjects: Relation to calcium metabolism
15. Simple test of intestinal calcium absorption measured by stable strontium
16. 3 levels in patients with idiopathic hypercalciuria and in normal subjects
17. Idiopathic hypercalciuria: The contribution of Dr. Jacob Lemann, Jr
18. Ambulatory evaluation of nephrolithiasis: An update of a 1980 protocol
19. The role of 1 alpha, 25 dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria
20. Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria
21. 2-vitamin D levels in humans: Studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism
22. Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria
23. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria
24. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers
25. Relative hypoparathyroidism and calcitriol up-regulation in hypercalciuric calcium renal stone formers: Impact of nutrition
26. Dietary polyunsaturated fatty acids and eicosanoid formation in humans
27. The protective role of eicosapentaenoic acid (EPA) in the pathogenesis of nephrolithiasis
28. Is arachidonic acid a second messenger in signal transduction?
29. New insights into the pathogenesis of idiopathic hypercalciuria: The role of bone
30. 1,25-dihydroxy-cholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone
31. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoblastic bone resorption
32. 2 vitamin D concentrations in healthy man
33. Evidence for a prostaglandin-mediated bone resorptive mechanism in subjects with fasting hypercalciuria
34. The role of prostaglandins in bone in vivo
35. 3
36. Transcriptional and posttranscriptional regulation of macrophage specific colony stimulation factor gene expression by tumor necrosis factor: Involvement of arachidonic acid metabolites
37. The effect on human tumor factor alpha and interleukin 1 beta production of diets enriched in ω-3 fatty acids from vegetable oil or fish oil
38. Bone marrow, cytokines, and bone remodeling
39. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria
40. Idiopathic hypercalciuria and osteoporosis-distinct clinical manifestations of increased cytokine-induced bone resorption?
41. Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: Effects of free urinary collagen cross-links, total urinary hydroxyproline, and bone calcium content
42. Spontaneous release of interleukin 1 from human blood monocytes reflects bone resorption in idiopathic osteoporosis
43. Specific modulatory effect of arachidonic acid on bone cytochine mRNA expression
44. Sensitivity to calcium intake in calcium stone forming patients
45. Replacement of molecular species of phosphatidylcholine: Influence on erytrocyte Na transport
46. Factors influencing fatty acid chain elongation and desaturation
47. Nutritional risk factors in calcium stone disease in Japan
48. The effect of dietary intake on urinary oxalate excretion in calcium renal stone formers